Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Short-term Investments (2010 - 2025)

Updated

Sinovac Biotech (SVA) recorded Short-term Investments of $5.48 billion in Q4 2025, down 43.0% from $9.61 billion a year earlier.

Analysis

Sinovac Biotech (SVA) Short-term Investments (2010 - 2025) Analysis & Trends

Starting with Q4 2010, Sinovac Biotech's Short-term Investments history includes 9 quarters.

  • Annual Short-term Investments has a five-year compound annual growth rate of 109.7% (FY2020 to FY2025).
  • Across earlier years, Short-term Investments came in at $9.61 billion in FY2024 (-2.8%), $9.89 billion in FY2023 (+48.7%), $6.65 billion in FY2022 (+268.3%) and $1.81 billion in FY2021.
  • The Q4 2025 figure is the lowest quarterly Short-term Investments since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Sinovac Biotech 464.94 Mn -35.05 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 5.48 Bn
Dec 31, 2024 9.61 Bn
Dec 31, 2023 9.89 Bn
Dec 31, 2022 6.65 Bn
Dec 31, 2021 1.81 Bn
Dec 31, 2020 135.25 Mn
Dec 31, 2019 50.27 Mn
Dec 31, 2018 18.91 Mn
Dec 31, 2010 1.51 Mn
API Access

Sinovac Biotech Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=SVA&period=max&api_key=YOUR_API_KEY